Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 3/2017

01-09-2017

Biography—Hidenori Inohara

Author: Hidenori Inohara

Published in: Cancer and Metastasis Reviews | Issue 3/2017

Login to get access

Excerpt

Dr. Hidenori Inohara is the Professor and Chair of the Department of Otorhinolaryngology—Head and Neck Surgery at Osaka University Graduate School of Medicine. After graduation from Osaka University Faculty of Medicine in 1987, Dr. Inohara moved to Osaka University Graduate School of Medicine, after receiving one year of clinical training. He developed the human tumor xenograft model in scid mice and earned a Ph.D. in 1992. He then worked as a postdoctoral fellow at the Karmanos Cancer Institute, Wayne State University in the USA, and engaged in research to clarify the roles of galectin-3 in cancer metastasis, under the direction of Dr. Avraham Raz. …
Metadata
Title
Biography—Hidenori Inohara
Author
Hidenori Inohara
Publication date
01-09-2017
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 3/2017
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-017-9696-7

Other articles of this Issue 3/2017

Cancer and Metastasis Reviews 3/2017 Go to the issue

OriginalPaper

Preface

OriginalPaper

The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma

OriginalPaper

Tobacco-related carcinogenesis in head and neck cancer

OriginalPaper

Targeting metabolic pathways for head and neck cancers therapeutics

OriginalPaper

Tumor DNA: an emerging biomarker in head and neck cancer

OriginalPaper

Alcohol and head and neck cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits